HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kjeldsberg, E. Articles by Flikke, M. Search for Related Content PubMed PubMed Citation Articles by Kjeldsberg, E. Articles by Flikke, M. Agricola Articles by Kjeldsberg, E. Articles by Flikke, M.

Antiviral Activity of Polyinosinic-Polycytidylic Acid in the Absence of Cell-controlled RNA Synthesis

Virusdepartment A, National Institute of Public Health, Geitmyrsveien 75, Oslo, Norway

When Detroit cells are infected with poliovirus in the presence of 5 µg./ml. of actinomycin, cell-controlled RNA synthesis is blocked and 2-[¹⁴C]uridine is incorporated only into poliovirus-specific RNA.

The addition of polyinosinic-polycytidylic acid (5 µg./ml.) under such conditions results in the inhibition of synthesis of 35 S intracellular, infectious poliovirus RNA.

A high molecular weight fraction of poliovirus-specific RNA migrating on polyacrylamide gels, as would be expected of the double-stranded, replicative form of poliovirus RNA, is synthesized to the same extent as in the absence of interferon inducer. This RNA was digested with RNase and DNase and was resistant to the enzymes, confirming that the compound was replicative form poliovirus RNA.

A low molecular weight, virus-induced RNA of 4S and unknown function is also synthesized independently of polyinosinic-polycytidylic acid.

The significance of the differential inhibition in the synthesis of the compounds presumed to be poliovirus RNA and replicative form poliovirus RNA, and the fact that the capacity of polyinosinic-polycytidylic acid to inhibit the synthesis of infectious RNA is insensitive to actinomycin, is discussed.

Received 30 June 1970; accepted 12 October 1970.